| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911477 | Lung Cancer | 2012 | 6 Pages |
Abstract
In this unplanned, exploratory subgroup analysis of advanced stage NSCLC ECOG trials, women â¥60 years old treated with chemotherapy live longer than men and younger women. In contrast, bevacizumab survival benefit was more pronounced in men of any age and in younger women on E4599.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
H.A. Wakelee, S.E. Dahlberg, J.R. Brahmer, J.H. Schiller, M.C. Perry, C.J. Langer, A.B. Sandler, C.P. Belani, D.H. Johnson, Eastern Cooperative Oncology Group Eastern Cooperative Oncology Group,